Authors: JOHNSTON JB DAENINCK P VERBURG L LEE K WILLIAMS G ISRAELS LG MOWAT MRA BEGLEITER A

Citation: Jb. Johnston et al., P53, MDM-2, BAX AND BCL-2 AND DRUG-RESISTANCE IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia & lymphoma, 26(5-6), 1997, pp. 435

Authors: BEGLEITER A WANG H VERBURG L LEE K ISRAELS LG MOWAT MRA JOHNSTON JB

Citation: A. Begleiter et al., IN-VITRO CYTOTOXICITY OF 2-CHLORODEOXYADENOSINE AND CHLORAMBUCIL IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia, 10(12), 1996, pp. 1959-1965

Authors: BEGLEITER A VERBURG L ASHIQUE A LEE K ISRAELS LG MOWAT MRA JOHNSTON JB

Citation: A. Begleiter et al., COMPARISON OF ANTITUMOR ACTIVITIES OF 2-CHLORODEOXYADENOSINE AND 9-BETA-AVABINOSYL-2-FLUOROADENINE IN CHRONIC LYMPHOCYTIC-LEUKEMIA AND MARROW-CELLS IN-VITRO, Leukemia, 9(11), 1995, pp. 1875-1881

Authors: DAENINCK PJ BEGLEITER A VERBURG L LEE K WILLIAMS G ISRAELS LG JOHNSTON JB

Citation: Pj. Daeninck et al., CORRELATION OF BAX, BCL-2 AND MDM-2 EXPRESSION WITH DRUG-SENSITIVITY IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), Blood, 86(10), 1995, pp. 1367-1367

Authors: JOHNSTON JB VERBURG L SHORE T WILLIAMS M ISRAELS LG BEGLEITER A

Citation: Jb. Johnston et al., COMBINATION THERAPY WITH NUCLEOSIDE ANALOGS AND ALKYLATING-AGENTS, Leukemia, 8, 1994, pp. 190000140-190000143

Authors: THLIVERIS JA BEGLEITER A KOBRINSKY NL VERBURG L DEAN HJ JOHNSTON JB

Citation: Ja. Thliveris et al., PREVENTION OF INSULIN-DEPENDENT DIABETES-MELLITUS BY 2'-DEOXYCOFORMYCIN IN THE BB WISTAR RAT, Biochemical pharmacology, 46(6), 1993, pp. 1071-1075